🚀 VC round data is live in beta, check it out!
Sisram Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Sisram Medical and similar public comparables like Sanara MedTech, CVRx, Inogen, JETEMA Co. and more.
Sisram Medical Overview
About Sisram Medical
Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The company is mainly involved in the design, development, manufacture, and sale of energy-based aesthetic medical and minimally invasive treatment systems, non-EBD devices, and cosmeceuticals. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Founded
2013
HQ
Employees
1.0K
Website
Financials (LTM)
EV
$172M
Sisram Medical Financials
Sisram Medical reported last 12-month revenue of $378M and EBITDA of $41M.
In the same LTM period, Sisram Medical generated $223M in gross profit, $41M in EBITDA, and $21M in net income.
Revenue (LTM)
Sisram Medical P&L
In the most recent fiscal year, Sisram Medical reported revenue of $349M and EBITDA of $52M.
Sisram Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $378M | XXX | $349M | XXX | XXX | XXX |
| Gross Profit | $223M | XXX | $217M | XXX | XXX | XXX |
| Gross Margin | 59% | XXX | 62% | XXX | XXX | XXX |
| EBITDA | $41M | XXX | $52M | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 15% | XXX | XXX | XXX |
| EBIT Margin | 8% | XXX | 10% | XXX | XXX | XXX |
| Net Profit | $21M | XXX | $25M | XXX | XXX | XXX |
| Net Margin | 5% | XXX | 7% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Sisram Medical Stock Performance
Sisram Medical has current market cap of $192M, and enterprise value of $172M.
Market Cap Evolution
Sisram Medical's stock price is $0.41.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $172M | $192M | 0.0% | XXX | XXX | XXX | $0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSisram Medical Valuation Multiples
Sisram Medical trades at 0.5x EV/Revenue multiple, and 4.2x EV/EBITDA.
EV / Revenue (LTM)
Sisram Medical Financial Valuation Multiples
As of April 20, 2026, Sisram Medical has market cap of $192M and EV of $172M.
Equity research analysts estimate Sisram Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Sisram Medical has a P/E ratio of 9.3x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $192M | XXX | $192M | XXX | XXX | XXX |
| EV (current) | $172M | XXX | $172M | XXX | XXX | XXX |
| EV/Revenue | 0.5x | XXX | 0.5x | XXX | XXX | XXX |
| EV/EBITDA | 4.2x | XXX | 3.3x | XXX | XXX | XXX |
| EV/EBIT | 5.6x | XXX | 4.8x | XXX | XXX | XXX |
| EV/Gross Profit | 0.8x | XXX | 0.8x | XXX | XXX | XXX |
| P/E | 9.3x | XXX | 7.6x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 11.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Sisram Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Sisram Medical Margins & Growth Rates
Sisram Medical's revenue in the last 12 month grew by 12%.
Sisram Medical's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Sisram Medical's rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Sisram Medical's rule of X is 40% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Sisram Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 12% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 11% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Growth | 3% | XXX | (21%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 22% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 40% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 35% | XXX | 38% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 10% | XXX | 10% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 5% | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 52% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Sisram Medical Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Sisram Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Sanara MedTech | XXX | XXX | XXX | XXX | XXX | XXX |
| CVRx | XXX | XXX | XXX | XXX | XXX | XXX |
| Inogen | XXX | XXX | XXX | XXX | XXX | XXX |
| JETEMA Co. | XXX | XXX | XXX | XXX | XXX | XXX |
| Deltex Medical Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sisram Medical M&A Activity
Sisram Medical acquired XXX companies to date.
Last acquisition by Sisram Medical was on XXXXXXXX, XXXXX. Sisram Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Sisram Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSisram Medical Investment Activity
Sisram Medical invested in XXX companies to date.
Sisram Medical made its latest investment on XXXXXXXX, XXXXX. Sisram Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Sisram Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Sisram Medical
| When was Sisram Medical founded? | Sisram Medical was founded in 2013. |
| Where is Sisram Medical headquartered? | Sisram Medical is headquartered in Israel. |
| How many employees does Sisram Medical have? | As of today, Sisram Medical has over 1K employees. |
| Is Sisram Medical publicly listed? | Yes, Sisram Medical is a public company listed on HKEX. |
| What is the stock symbol of Sisram Medical? | Sisram Medical trades under 01696 ticker. |
| When did Sisram Medical go public? | Sisram Medical went public in 2017. |
| Who are competitors of Sisram Medical? | Sisram Medical main competitors are Sanara MedTech, CVRx, Inogen, JETEMA Co.. |
| What is the current market cap of Sisram Medical? | Sisram Medical's current market cap is $192M. |
| What is the current revenue of Sisram Medical? | Sisram Medical's last 12 months revenue is $378M. |
| What is the current revenue growth of Sisram Medical? | Sisram Medical revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of Sisram Medical? | Current revenue multiple of Sisram Medical is 0.5x. |
| Is Sisram Medical profitable? | Yes, Sisram Medical is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Sisram Medical? | Sisram Medical's last 12 months EBITDA is $41M. |
| What is Sisram Medical's EBITDA margin? | Sisram Medical's last 12 months EBITDA margin is 11%. |
| What is the current EV/EBITDA multiple of Sisram Medical? | Current EBITDA multiple of Sisram Medical is 4.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.